Clevudine Terminated Phase 3 Trials for Viral Hepatitis B Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00313287Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
NCT00313274Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
NCT00362505Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials